Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: February 16, 2011
Last updated: March 11, 2015
Last verified: March 2015